Syndax Announces Data Presentations at EHA 2025 Showcasing Revuforj® (revumenib) and Niktimvo™ (axatilimab-csfr) Syndax Pharmaceuticals, Inc. Wed, May 14, 2025, 6:30 AM 15 min read.

Rhythm Pharmaceuticals, Inc.-- New data showed setmelanotide achieved consistent, meaningful weight reduction ---- Multiple presentations delivered at the first-ever Joint Congress between the ...

Tesla’s head of AI, Andrej Karpathy, released a bunch of new data about Autopilot and its features in a new presentation. Unlike most automakers and tech companies working on autonomous driving ...

Oral presentation features new data from the 24-week pivotal Vivacity-MG3 study which show sustained disease control through treatment with nipocalimab on the clinician-assessed QMGa score in ...

These data support our plans to commence a Phase 2 clinical trial in patients with multiple sclerosis in the second half of this year.” Details regarding the February 28, 2025 , presentations ...

The wide-ranging presentation at GigaOM's Structure:Data conference in New York City came two days after it was reported the spy agency is on the verge of signing a cloud computing contract with ...